|
76
|
Senti Biosciences Holdings
|
28
|
+4
|
+17%
|
$7.64M
|
|
|
77
|
|
28
|
0
|
0%
|
$69.9M
|
|
|
78
|
|
27
|
-21
|
-44%
|
$3.94M
|
|
|
79
|
|
25
|
-14
|
-36%
|
$50.2M
|
|
|
80
|
DELISTED
NKGen Biotech, Inc. Common Stock
|
25
|
-30
|
-55%
|
$63M
|
|
|
81
|
|
24
|
-2
|
-8%
|
$39M
|
|
|
82
|
|
23
|
0
|
0%
|
$4.43M
|
|
|
83
|
|
22
|
+5
|
+29%
|
$3.59M
|
|
|
84
|
DELISTED
Orgenesis Inc. Common Stock
|
22
|
+2
|
+10%
|
$3.04M
|
|
|
85
|
|
20
|
-1
|
-5%
|
$6.77M
|
|
|
86
|
|
19
|
0
|
0%
|
$795K
|
|
|
87
|
|
19
|
+4
|
+27%
|
$2.71M
|
|
|
88
|
DELISTED
Achilles Therapeutics
|
18
|
0
|
0%
|
$18.7M
|
|
|
89
|
|
18
|
+6
|
+50%
|
$1.75M
|
|
|
90
|
|
17
|
-4
|
-19%
|
$5.57M
|
|
|
91
|
|
17
|
-1
|
-6%
|
$3.64M
|
|
|
92
|
DELISTED
Scorpius Holdings, Inc.
|
17
|
-3
|
-15%
|
$1.48M
|
|
|
93
|
|
16
|
-2
|
-11%
|
$515K
|
|
|
94
|
DELISTED
Sigilon Therapeutics, Inc. Common Stock
|
16
|
-16
|
-50%
|
$26.6M
|
|
|
95
|
|
14
|
+7
|
+100%
|
$5.5M
|
|
|
96
|
|
12
|
-2
|
-14%
|
$1.42M
|
|
|
97
|
DELISTED
CERo Therapeutics
|
12
|
-3
|
-20%
|
$10.6M
|
|
|
98
|
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
|
11
|
-4
|
-27%
|
$5.09M
|
|
|
99
|
|
10
|
0
|
0%
|
$750K
|
|
|
100
|
Creative Medical Technology
|
9
|
-6
|
-40%
|
$96.2K
|
|